|
Name |
Pyrenocine A
|
Molecular Formula | C11H12O4 | |
IUPAC Name* |
5-[(E)-but-2-enoyl]-4-methoxy-6-methylpyran-2-one
|
|
SMILES |
C/C=C/C(=O)C1=C(OC(=O)C=C1OC)C
|
|
InChI |
InChI=1S/C11H12O4/c1-4-5-8(12)11-7(2)15-10(13)6-9(11)14-3/h4-6H,1-3H3/b5-4+
|
|
InChIKey |
VVYCRPVWBIEKIW-SNAWJCMRSA-N
|
|
Synonyms |
Pyrenocine A; Pyrenocin A; 76868-97-8; 5-[(E)-but-2-enoyl]-4-methoxy-6-methylpyran-2-one; Pyrenocin A putative; 3M9PWU4VLX; CHEMBL4452052; DTXSID801017472; 5-crotonoyl-4-methoxy-6-methyl-pyrone; 2H-Pyran-2-one, 4-methoxy-6-methyl-5-(1-oxo-2-butenyl)-, (E)-; 4-Methoxy-6-methyl-5-[(2E)-1-oxo-2-buten-1-yl]-2H-pyran-2-one; 2H-Pyran-2-one, 4-methoxy-6-methyl-5-[(2E)-1-oxo-2-buten-1-yl]-
|
|
CAS | 76868-97-8 | |
PubChem CID | 6312351 | |
ChEMBL ID | CHEMBL4452052 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 208.21 | ALogp: | 1.1 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 52.6 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.565 |
Caco-2 Permeability: | -4.572 | MDCK Permeability: | 0.00002050 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.987 |
Blood-Brain-Barrier Penetration (BBB): | 0.129 | Plasma Protein Binding (PPB): | 79.22% |
Volume Distribution (VD): | 0.99 | Fu: | 15.97% |
CYP1A2-inhibitor: | 0.944 | CYP1A2-substrate: | 0.948 |
CYP2C19-inhibitor: | 0.242 | CYP2C19-substrate: | 0.531 |
CYP2C9-inhibitor: | 0.043 | CYP2C9-substrate: | 0.78 |
CYP2D6-inhibitor: | 0.026 | CYP2D6-substrate: | 0.812 |
CYP3A4-inhibitor: | 0.053 | CYP3A4-substrate: | 0.38 |
Clearance (CL): | 10.791 | Half-life (T1/2): | 0.744 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.606 |
Drug-inuced Liver Injury (DILI): | 0.42 | AMES Toxicity: | 0.412 |
Rat Oral Acute Toxicity: | 0.88 | Maximum Recommended Daily Dose: | 0.215 |
Skin Sensitization: | 0.631 | Carcinogencity: | 0.889 |
Eye Corrosion: | 0.654 | Eye Irritation: | 0.984 |
Respiratory Toxicity: | 0.976 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005955 | 1.000 | D05QDC | 0.253 | ||||
ENC005954 | 0.600 | D0T3NY | 0.246 | ||||
ENC005957 | 0.560 | D0B1IP | 0.236 | ||||
ENC006029 | 0.545 | D0E6OC | 0.230 | ||||
ENC005956 | 0.545 | D0E9CD | 0.228 | ||||
ENC003263 | 0.509 | D0FA2O | 0.225 | ||||
ENC003262 | 0.444 | D0G4KG | 0.224 | ||||
ENC005634 | 0.431 | D08VYV | 0.221 | ||||
ENC001413 | 0.400 | D03LGG | 0.217 | ||||
ENC001650 | 0.400 | D0U5CE | 0.217 |